ar-c239 has been researched along with silodosin in 1 studies
Studies (ar-c239) | Trials (ar-c239) | Recent Studies (post-2010) (ar-c239) | Studies (silodosin) | Trials (silodosin) | Recent Studies (post-2010) (silodosin) |
---|---|---|---|---|---|
45 | 0 | 5 | 317 | 74 | 211 |
Protein | Taxonomy | ar-c239 (IC50) | silodosin (IC50) |
---|---|---|---|
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0901 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0168 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0019 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.3287 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 8.0716 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, MY; Tsai, KC; Xia, L | 1 |
1 other study(ies) available for ar-c239 and silodosin
Article | Year |
---|---|
Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Evaluation, Preclinical; Expert Systems; Humans; Models, Molecular; Receptors, Adrenergic, alpha-1; Software; Structure-Activity Relationship | 2005 |